NAMPT and polycystic ovary syndrome: Visfatin gene expression in PBMMs was greater than that observed in PBMCs of the non-PCOS participants (P=0.014), however, was not significantly increased in the PCOS patients (P=0.21), IR patients (P=0.06) or the non-IR participants (P=0.064).